Sufficient control of heartburn in endoscopy-negative gastro-oesophageal reflux disease trials.
Junghard
O
O
Dept. of Clinical Science, AstraZeneca R&D Mölndal, Sweden. ola.junghard@astrazeneca.com
Carlsson
R
R
Lind
T
T
D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D016099:Endoscopy, Gastrointestinal; D004942:Esophagitis, Peptic / Q000175:diagnosis; D005260:Female; D005764:Gastroesophageal Reflux / Q000175:diagnosis*; D006356:Heartburn / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009853:Omeprazole / Q000627:therapeutic use*; D011795:Surveys and Questionnaires
D000897:Anti-Ulcer Agents; D009853:Omeprazole